Junxun Ma - First Department of Medical Oncology, Chinese PLA General Hospital

基本信息

浏览量：14

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 67 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Surufatinib plus PD-1/L1 inhibitors as maintenance therapy following first line (1L) platinum-based chemotherapy combined with PD-1/L1 inhibitors in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)

Yi Hu,Jianhua Chen,Dongqing Lv,Jinliang Wang,Junxun Ma,Tienan Yi,Shikai Wu,Xiangdong Zhou, Xingxing Zhang,Dongmei Chen,Songhua Fan,Michael Shi,Weiguo Su

Journal of Clinical Oncologyno. 16_suppl (2024)

引用0浏览0引用

Treatment Strategies with Combined Agency Against Severe Viral Pneumonia in Patients with Advanced Cancer

Fan Zhang,Tao Li,Yibing Bai, Jiayi Liu,Jiapei Qin,An Wang, Yimin Zhu,Min Zhang, Zhiqiang Ma, Xin Zhou,Lijie Wang, Ming Gao, Xiaodong Wu, Yan Shao,Xiangfei Zhao,Juyi Wen,Jingzhi Guan,Jinliang Wang,Junxun Ma,Haitao Tao,Yi Hu

PubMed（2024）

引用0浏览0WOS引用

Pralsetinib-associated Pneumonia in RET Fusion-Positive Non-Small Cell Lung Cancer

Ming Gao,Xia Zhang,Huan Yan,Decong Sun,Xuejiao Yang,Fang Yuan,Yanfang Ju,Lijie Wang,Jinliang Wang,Wei Zhao,Dong Zhang,Lin Li,Xiaoyun Xu,Junxun Ma,Yi Hu,Xiaotao Zhang

Supportive Care in Cancerno. 12 (2023)

引用0浏览0WOS引用

Comparison of Efficacy and Safety Between PD-1 Inhibitors and PD-L1 Inhibitors Plus Platinum-Etoposide As First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer: a Multicenter, Real-World Analysis

Yanrong Wang,Lingling Li,Jia Hu, Yan Zhao,Huan Yan,Ming Gao,Xuejiao Yang,Xia Zhang,Junxun Ma,Guanghai Dai

BMC Cancer（2023）

引用0浏览0WOS引用

Efficacy and Safety of Immune Checkpoint Inhibitor Without Pemetrexed for First-Line Maintenance Therapy in Advanced Lung Adenocarcinoma

Ming Gao,Wenyu Yang,Chunyu Wang,Ting Wang,Fangfang Jing,Fan Zhang,Haitao Tao,Junxun Ma,Yi Hu,Lijie Wang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Deciphering Pathogenic Cellular Module at Single-Cell Resolution in Checkpoint Inhibitor-Related Pneumonitis

Pengfei Cui,Jinfeng Li,Haitao Tao, Xiaoyan Li,Liangliang Wu,Junxun Ma,Huanhuan Wang,Tingting Liu,Min Zhang,Yi Hu

Oncogene（2023）

引用1浏览0WOSNATURE引用

Programmed Cell Death Protein 1 Inhibitor-Mediated Peripheral Neuropathy

Yanyun Ao, Ming Gao, Bin Sun,Hong-Jun Hao, Hongyuan Yan, Chuntong Li, Dan Sun, Xiaojing Yang,Yanfang Ju,Xia Zhang,Junxun Ma

JTO clinical and research reportsno. 4 (2023): 100495-100495

引用0浏览0引用

131P First-line HDACi Plus Tislelizumab Combined with Chemotherapy in Advanced NSCLC

Lijie Wang, Ming Gao, Wenyu Yang,Chunyu Wang, Ting Wang,Fangfang Jing,Junxun Ma,Fan Zhang,Haitao Tao, Yi Hu

Journal of Clinical Oncologyno. 16_suppl (2023): e21100-e21100

引用0浏览0引用

Immune Checkpoint Inhibitor without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A real-world retrospective study

Ming Gao,Wenyu Yang, Ting Wang,Fangfang Jing,Fan Zhang,Haitao Tao,Junxun Ma,Yi Hu,Lijie Wang

Research Square (Research Square) (2023)

引用0浏览0引用

Outcome of Immune Checkpoint Inhibitors in Patients with Extensive-Stage Small-Cell Lung Cancer and Brain Metastases

Chunyu Wang,Fangfang Jing, Fan Zhang,Haitao Tao,Junxun Ma,Yi Hu, Lijie Wang

Journal of Clinical Oncology（2023）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn